Glucose-Lösung Deltamedica

Glucose-Lösung Deltamedica is an intravenous solution for injection that contains the active ingredient Glucose, Anhydrous. It is supplied as a sterile solution without a specified concentration and is classified as an excipient/solvent used in parenteral nutrition. The product is authorized for prescription use within the European Union market.

Glucose-Lösung Deltamedica is employed in clinical settings where rapid carbohydrate delivery is required. It supports several therapeutic objectives:

- Treatment of hypoglycemia by raising blood glucose levels. - Provision of an energy substrate during parenteral nutrition. - Fluid and electrolyte replacement in patients unable to take oral intake. - Support during perioperative care to maintain glucose homeostasis. - Adjunctive therapy in critical care for metabolic support.

Glucose-Lösung Deltamedica may be associated with a range of adverse reactions, most of which are related to its intravenous administration.

Common: - Local irritation at the infusion site. - Mild hyperglycemia. - Nausea or vomiting. - Transient electrolyte imbalance.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic or anaphylactic reaction. - Phlebitis or thrombophlebitis. - Fluid overload, especially in patients with cardiac or renal impairment.

When using Glucose-Lösung Deltamedica, clinicians should consider several safety measures to minimize risk:

- Assess blood glucose levels before and during infusion. - Adjust infusion rate in patients with diabetes or impaired glucose tolerance. - Monitor fluid balance to avoid overload in heart failure or renal disease. - Use aseptic technique to prevent contamination and infection. - Evaluate electrolyte status, particularly sodium and potassium, during therapy. - Document any signs of hypersensitivity promptly.

Glucose-Lösung Deltamedica can interact with other medications or clinical conditions, requiring careful management.

Avoid: - Concurrent administration of high‑dose insulin without appropriate glucose monitoring. - Co‑infusion with solutions containing incompatible electrolytes (e.g., calcium chloride).

Use with caution: - Beta‑blockers, which may mask hypoglycemia symptoms. - Corticosteroids, which can increase blood glucose levels. - Diuretics that may alter fluid and electrolyte balance. - Medications that affect renal function, such as ACE inhibitors.